Artio Medical Closes $28M In Additional Series A Financing

Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million. Funds will be used to support US commercialization efforts for the recently cleared Solus GoldTM Embolization Device and to accelerate the development of Artio's broad portfolio of products, including expanding the Company's engineering and manufacturing capabilities.